Federal Medical Centre (FMC) Jabi Denies Claims of Anti-Venom Shortage in Singer Nanyah’s Death

The Federal Medical Centre (FMC) in Jabi, Abuja, has issued a statement directly contradicting widespread reports surrounding the death of singer Ifunanya ‘Nanyah’ Nwagene.

The hospital asserts that anti-snake venom was available and administered to Nanyah upon her arrival, countering allegations from her family and public commentary that she was turned away due to a lack of the medication.

According to the hospital, she received immediate care, including resuscitation, oxygen, and the polyvalent antivenom, but had already developed severe neurotoxic complications.

Her condition reportedly deteriorated suddenly during preparations to transfer her to the Intensive Care Unit, and despite resuscitation efforts, she could not be revived.

Key Points:

The official statement directly challenges the central narrative of systemic failure, instead attributing the tragedy to the rapid progression of a medical condition.

It places the hospital’s response and resource availability in direct opposition to the firsthand account provided by the victim’s brother, creating conflicting narratives.

The defence shifts the focus from an alleged drug shortage to the medical complexities and fatality rate of advanced envenomation.
Public scepticism in the reaction highlights a deep-seated distrust in institutional accounts, especially following emotionally charged personal testimonies.

The incident underscores the critical communication gap and crisis of credibility between public healthcare institutions and the citizens they serve.

With two contradictory accounts now in the public domain, the tragedy has escalated from a case of alleged neglect to a pivotal moment testing public trust in official narratives versus personal testimony.

Sources: Daily Post, Premium Times, The Cable

𝙍𝙚𝙖𝙙 𝙩𝙝𝙚 𝙇𝙖𝙩𝙚𝙨𝙩 𝙎𝙥𝙤𝙧𝙩 𝙏𝙧𝙚𝙣𝙙𝙨 𝙖𝙣𝙙 𝙂𝙚𝙩 𝙁𝙧𝙚𝙨𝙝 𝙪𝙥𝙙𝙖𝙩𝙚𝙨 𝙖𝙨 𝙩𝙝𝙚𝙮 𝙙𝙧𝙤𝙥 𝙫𝙞𝙖 [𝙏𝙬𝙞𝙩𝙩𝙚𝙧] 𝙓 𝙖𝙣𝙙 𝙁𝙖𝙘𝙚𝙗𝙤𝙤𝙠 And Whatsapp Channel Now

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More